RED BANK, NJ--(Marketwire - Jan 9, 2012) - TGI SOLAR POWER GROUP INC. (PINKSHEETS: [ TSPG ]), a diversified energy company, is pleased to announce it has placed an order for an EKOPLAZ E5 medical waste and hazardous materials processing unit.

TSPG Management plans to test this experimental unit using MSW, demolition materials, coal (clean burn) and medical waste for feedstock.

Learn more about EKOPLAZ and our leading edge technologies by visiting our web site at TGI Group (TSPG), TGI SOLAR POWER GROUP INC. ([ www.tgisolar.com ])

The company plans to release more exciting news and details about this exciting project on a timely basis, to the company followers.

About EKOPLAZ

EKOPLAZ has developed the technology based on high-frequency disruption in an electromagnetic microwave field. High field intensity provides air ionization in the location of the disruption along with the release of high temperature. Special configuration of the air ionization chamber allows the supply of middle and large microwave capacity to provide the initiation of a stable plasma flame at the output of the plasmatron nozzle. This technology offers significant advantages including: medical waste treatment, pesticide utilization or domestic industrial waste processing. A plant can be implemented both in mobile and stationary usage occurring in a continuous operation or on as-needed basis.

About TGI Solar

TGI SOLAR POWER GROUP INC. ([ www.tgisolar.com ]) is a diversified holding company. The Company offers its products and services to clients on a worldwide basis and currently maintains JVs and strategic alliances with installation, integration and energy consulting firms. TGI's strategy is to acquire new patented technologies, components, processes, designs and methods with commercial value that will give market advantage and generate shareholder value.

Safe Harbor Statements under the Private Securities Litigation Reform Act of 1965: Those statements contained herein which are not historical are forward-looking statements, and as such, are subject to risks and uncertainties that could cause actual operating results to materially differ from those contained in the forward-looking statements. Such statements include, but are not limited to, certain delays that are beyond the company's control, with respect to market acceptance of new technologies, or product delays in the testing and evaluation of products, and other risks, as detailed in the company's periodic filings with the Securities and Exchange Commission.